Haleon (HLN) Non-Current Deferred Tax Liability (2021 - 2025)

Haleon (HLN) posted Non-Current Deferred Tax Liability of $4.3 billion for Q4 2025, little changed on a QoQ basis from $4.3 billion in Q4 2024, and little changed year-over-year from $4.3 billion in Q4 2024.

Haleon (HLN) Non-Current Deferred Tax Liability (2021 - 2025) Analysis & Trends

Haleon's Non-Current Deferred Tax Liability history runs 5 years deep, the most recent figure standing at $4.3 billion for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability changed 0.41% year-over-year to $4.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.3 billion (changed 0.41% YoY) and the FY2025 annual result came in at $4.2 billion, down 0.88% from the prior year.
  • Non-Current Deferred Tax Liability was $4.3 billion for Q4 2025 at Haleon, roughly flat from $4.3 billion in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $4.5 billion in Q4 2021 and bottomed at -$4.6 billion in Q2 2022.
  • A 5-year average of $1.1 billion and a median of $4.3 billion in 2025 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability retreated 6.66% — and 2023, when it climbed 6.5%.
  • Haleon's Non-Current Deferred Tax Liability stood at $4.5 billion in 2021, then declined by 6.66% to $4.2 billion in 2022, then advanced by 2.47% to $4.3 billion in 2023, then slipped by 0.56% to $4.3 billion in 2024, then decreased by 0.41% to $4.3 billion in 2025.
  • Business Quant data shows HLN's Non-Current Deferred Tax Liability at $4.3 billion in Q4 2025, $4.3 billion in Q4 2024, and -$4.2 billion in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.29 Bn
Dec 31, 2025 4.29 Bn
Dec 31, 2024 4.30 Bn
Dec 31, 2024 4.30 Bn
Jun 30, 2024 -4.22 Bn
Jun 30, 2024 -4.22 Bn
Dec 31, 2023 4.33 Bn
Dec 31, 2023 4.33 Bn
Jun 30, 2023 -4.30 Bn
Jun 30, 2023 -4.30 Bn
Dec 31, 2022 4.22 Bn
Dec 31, 2022 4.22 Bn
Jun 30, 2022 -4.60 Bn
Jun 30, 2022 -4.60 Bn
Dec 31, 2021 4.53 Bn
Dec 31, 2021 4.53 Bn